The estimated Net Worth of Bioventures V, L.P.Evnin Lu... is at least 133 百万$ dollars as of 10 October 2017. Bioventures Lu owns over 100,000 units of Rhythm Pharmaceuticals stock worth over 132,959,090$ and over the last 7 years Bioventures sold RYTM stock worth over 0$.
Bioventures has made over 1 trades of the Rhythm Pharmaceuticals stock since 2017, according to the Form 4 filled with the SEC. Most recently Bioventures bought 100,000 units of RYTM stock worth 1,700,000$ on 10 October 2017.
The largest trade Bioventures's ever made was buying 100,000 units of Rhythm Pharmaceuticals stock on 10 October 2017 worth over 1,700,000$. On average, Bioventures trades about 100,000 units every 0 days since 2017. As of 10 October 2017 Bioventures still owns at least 2,696,392 units of Rhythm Pharmaceuticals stock.
You can see the complete history of Bioventures Lu stock trades at the bottom of the page.
Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over 83,445,563$ worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth 106,961,700$ . The most active insiders traders include Forest Baskett、Scott D Sandell、Peter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of 3,358,405$. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth 77,963$.
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include: